The use of artificial intelligence (AI) in neuropsychiatric drug discovery: current challenges and future directions

Soyal James, Tarun Bastiampillai, Lyle J. Palmer, Pramod C. Nair

Open source

DOI
10.1038/s41398-026-04153-9
Published
2026-07-09
Container
Translational Psychiatry
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41398-026-04153-9,
  title = {The use of artificial intelligence (AI) in neuropsychiatric drug discovery: current challenges and future directions},
  author = {Soyal James and Tarun Bastiampillai and Lyle J. Palmer and Pramod C. Nair},
  year = {2026},
  journal = {Translational Psychiatry},
  doi = {10.1038/s41398-026-04153-9},
  url = {https://doi.org/10.1038/s41398-026-04153-9}
}

RIS

TY  - JOUR
TI  - The use of artificial intelligence (AI) in neuropsychiatric drug discovery: current challenges and future directions
AU  - Soyal James
AU  - Tarun Bastiampillai
AU  - Lyle J. Palmer
AU  - Pramod C. Nair
PY  - 2026
JO  - Translational Psychiatry
DO  - 10.1038/s41398-026-04153-9
UR  - https://doi.org/10.1038/s41398-026-04153-9
ER  - 

APA

James, S., Bastiampillai, T., Palmer, L. J., & Nair, P. C. (2026). The use of artificial intelligence (AI) in neuropsychiatric drug discovery: current challenges and future directions. Translational Psychiatry. https://doi.org/10.1038/s41398-026-04153-9

Source records